China Approves Expanded Release Of AstraZeneca Anaemia Drug
(Alliance News) - AstraZeneca PLC announced Chinese approval for roxadustat in non-dialysis-dependent patients on Thursday, as well as the USD95 million purchase of a priority review voucher in Co Read More